Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice

被引:7
作者
Pelletier, Lysanne [1 ]
Baillargeon, Jean-Patrice [1 ]
机构
[1] Univ Sherbrooke, Dept Med, Div Endocrinol, Sherbrooke, PQ J1H 5N4, Canada
关键词
Polycystic ovary syndrome; obesity; weight loss; weight management; lifestyle modification; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE MODIFICATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; RISK; HYPERTENSION; IMPROVEMENT; PREVALENCE; MANAGEMENT; METFORMIN;
D O I
10.1016/j.fertnstert.2010.02.047
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the proportion of obese women with polycystic ovary syndrome (PCOS) losing clinically significant amounts of weight during a standard follow-up by an endocrinologist. Design: Retrospective cohort study. Setting: Reproductive Endocrinology Clinic of an academic center. Patient(s): Obese patients with PCOS assessed between May 2002 and September 2008. Intervention(s): General nonstandardized advice on weight loss and exercise. Main Outcome Measure(s): Proportion of women losing >= 5% or >= 10% of their initial weight at each of the following time interval: 2-6 months, 6-12 months, 12-18 months, 18-24 months, 24-36 months, and beyond 36 months. Result(s): One hundred seventeen patients with PCOS and with a mean body mass index (BMI) of 38.7 kg/m(2) and mean age of 28.5 years were followed-up for a median duration of 21.9 months (range, 2.0-61.8 months), with a median of two visits per year. More than 40% of these women lost >= 5% of their initial weight after >6 months of follow-up, and >= 20% lost >= 10% after 1 year of follow-up. More important, these proportions were maintained up to >= 3 years. Conclusion(s): It is possible for obese women with PCOS to achieve clinically significant and sustained weight loss by following simple advices given in a regular clinical care setting. Therefore, practitioners should not underestimate their impact to facilitate weight loss in women with PCOS. (Fertil Steril (R) 2010;94:2665-9. (C) 2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:2665 / 2669
页数:5
相关论文
共 44 条
  • [1] Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc19-S002, 10.2337/dc12-S064, 10.2337/dc23-S002, 10.2337/dc09-S062, 10.2337/dc18-S002]
  • [2] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2745 - 2749
  • [3] Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
    Azziz, Ricardo
    Carmina, Enrico
    Dewailly, Didier
    Diamanti-Kandarakis, Evanthia
    Escobar-Morreale, Hector F.
    Futterweit, Walter
    Janssen, Onno E.
    Legro, Richard S.
    Norman, Robert J.
    Taylor, Ann E.
    Witchel, Selma F.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4237 - 4245
  • [4] Baillargeon Jean-Patrice, 2005, Curr Opin Investig Drugs, V6, P1012
  • [5] Integrated obesity care management system - implementation and research protocol
    Baillargeon, Jean-Patrice
    Carpentier, Andre
    Donovan, Denise
    Fortin, Martin
    Grant, Andrew
    Simoneau-Roy, Judith
    St-Cyr-Tribble, Denise
    Xhignesse, Mariane
    Langlois, Marie-France
    [J]. BMC HEALTH SERVICES RESEARCH, 2007, 7 (1)
  • [6] Commentary: Polycystic ovary syndrome: A syndrome of ovarian hypersensitivity to insulin?
    Baillargeon, JP
    Nestler, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) : 22 - 24
  • [7] Baillargeon JP., 2009, DIAGNOSIS MANAGEMENT, P209, DOI [10.1007/978-0-387-09718-3_18, DOI 10.1007/978-0-387-09718-3_18]
  • [8] Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: A 12-month, double-blind, parallel clinical trial
    Calaf, J.
    Lopez, E.
    Millet, A.
    Alcan, J.
    Fortuny, A.
    Vidal, O.
    Callejo, J.
    Escobar-Jimenez, F.
    Torres, E.
    Espinos, J. J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (09) : 3446 - 3452
  • [9] Obesity and mortality
    Calle, EE
    Teras, LR
    Thun, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) : 2197 - 2199
  • [10] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25